NCT05842616

Brief Summary

The aim of our study is to compare between transcranial doppler pulsatility index and mean arterial blood pressure in guiding management of sepsis induced encephalopathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable sepsis

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

1.2 years

First QC Date

April 15, 2023

Last Update Submit

August 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intensive care unit (ICU) mortality

    Incidence of Intensive care unit (ICU) stay will be recorded

    28 day or till death which earlier

Secondary Outcomes (6)

  • Mean arterial pressure

    24 hours

  • Norepinephrine titration

    24 hours

  • Cerebral perfusion pressure

    24 hours

  • Outcome of encephalopathy

    28 day

  • SOFA score

    Up to 4 weeks.

  • +1 more secondary outcomes

Study Arms (2)

Transcranial doppler pulsatility index guided protocol

EXPERIMENTAL

Norepinephrine titration that will be guided by Transcranial doppler (TCD) pulsatility index.

Other: Transcranial doppler pulsatility index guided protocol

Mean arterial blood pressure guided protocol

ACTIVE COMPARATOR

Norepinephrine titration that will be guided by Mean arterial blood pressure (MAP).

Other: Mean arterial blood pressure guided protocol

Interventions

Norepinephrine titration that will be guided by Transcranial doppler pulsatility index.

Transcranial doppler pulsatility index guided protocol

Norepinephrine titration that will be guided by Mean arterial blood pressure (MAP).

Mean arterial blood pressure guided protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or older
  • Must had clinical diagnosis of sepsis induced encephalopathy.

You may not qualify if:

  • Refusal to participate in the study.
  • Cerebral infection.
  • Known cerebral lesions (Neoplasm, Traumatic brain injury, Stroke, Ischemic or hemorrhagic cerebrovascular lesions, high intracranial pressure).
  • Known severe carotid stenosis (\>70%).
  • Intoxication due to drugs.
  • Pregnancy.
  • Patients supported by intra-aortic balloon pumb (IABP).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University Hospitals

Tanta, Elgharbia, 31527, Egypt

Location

Related Publications (1)

  • Salem MS, Abosabaa MA, Abd El Ghafar MS, Ei-Gendy HMEM, Alsherif SEI. Norepinephrine titration in patients with sepsis-induced encephalopathy: cerebral pulsatility index compared to mean arterial pressure guided protocol: randomized controlled trial. BMC Anesthesiol. 2025 Jan 4;25(1):5. doi: 10.1186/s12871-024-02814-0.

MeSH Terms

Conditions

SepsisBrain Diseases

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Mai S Aboshaara, MD

    Assistant lecturer

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

April 15, 2023

First Posted

May 6, 2023

Study Start

May 1, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

August 6, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author

Locations